@article{42c3f1c99dfc450e9a5759f43b7bba40,
title = "Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup",
abstract = "Nonsteroidal antiandrogen monotherapy may be a treatment option for some patients with advanced prostate cancer. We report a survival and safety update from an analysis of 2 studies in which patients with nonmetastatic (M0) locally advanced disease were treated with either 150 mg. bicalutamide monotherapy or castration.",
keywords = "Androgen Antagonists, Anilides, Castration, Disease Progression, Follow-Up Studies, Humans, Male, Multicenter Studies as Topic, Nitriles, Prostatic Neoplasms, Randomized Controlled Trials as Topic, Survival Analysis, Tosyl Compounds",
author = "P Iversen and Tyrrell, {C J} and Kaisary, {A V} and Anderson, {J B} and {Van Poppel}, H and Tammela, {T L} and M Chamberlain and K Carroll and I Melezinek",
year = "2000",
language = "English",
volume = "164",
pages = "1579--82",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Wolters Kluwer Health",
number = "5",
}